U.S. Markets open in 35 mins

Free Technical Reports on InspireMD and Three Additional Medical Equipment Equities

Stock Research Monitor: GMED, LNTH, and LIVN

LONDON, UK / ACCESSWIRE / July 10, 2018 / If you want a free Stock Review on NSPR sign up now at www.wallstequities.com/registration. On Monday, the NASDAQ Composite ended the day at 7,756.20, up 0.88%; the Dow Jones Industrial Average edged 1.31% higher, to finish at 24,776.59; and the S&P 500 closed at 2,784.17, marginally gaining 0.88%. Gains were broad based as eight out of nine sectors finished the trading session in green. WallStEquities.com has initiated research reports on the following Medical Appliances & Equipment stocks: Globus Medical Inc. (NYSE: GMED), InspireMD Inc. (NYSE AMER: NSPR), Lantheus Holdings Inc. (NASDAQ: LNTH), and LivaNova PLC (NASDAQ: LIVN). All you have to do is sign up today for this free limited time offer by clicking the link below.


Globus Medical

Audubon, Pennsylvania headquartered Globus Medical Inc.'s stock finished Monday's session 0.78% higher at $51.86 with a total trading volume of 276,476 shares. The stock has gained 60.41% in the previous twelve months. The Company's shares are trading above their 200-day moving average by 17.20%. Moreover, shares of Globus Medical, which focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders, have a Relative Strength Index (RSI) of 46.56.

On June 27th, 2018, research firm Bank of America/ Merrill downgraded the Company's stock rating from 'Neutral' to 'Underperform'. Get the full research report on GMED for free by clicking below at:



Shares in Tel Aviv, Israel headquartered InspireMD Inc. declined 2.48%, ending yesterday's session at $0.24 with a total trading volume of 743,828 shares. The Company's shares are trading below their 50-day moving average by 77.05%. Moreover, shares of InspireMD, which focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases, have an RSI of 14.66. Today's complimentary research report on NSPR is accessible at:


Lantheus Holdings

On Monday, North Billerica, Massachusetts headquartered Lantheus Holdings Inc.'s stock saw a rise of 2.34%, to close the day at $15.30. A total volume of 193,746 shares was traded. The Company's shares have advanced 5.88% in the last month. The stock is trading above its 50-day moving average by 1.92%. Additionally, shares of Lantheus Holdings, which develops, manufactures, and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases worldwide, have an RSI of 56.92. Register now for your free research document on LNTH at:



Shares in London, the UK headquartered LivaNova PLC ended the day 0.11% higher at $104.10. A total volume of 168,353 shares was traded. The stock has gained 21.68% in the previous three months and 66.19% over the last twelve months. The Company's shares are trading above their 50-day and 200-day moving averages by 11.82% and 22.67%, respectively. Furthermore, shares of LivaNova, which designs, develops, manufactures, and sells therapeutic solutions worldwide, have an RSI of 65.67. Click on the link below and see our free report LIVN at:


Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.


WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit



For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities